Clinical Trial Update: The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 trial evaluating toripalimab plus radiotherapy for operable stage II-IIIA (N+) non-small cell lung cancer; enrollment is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: NSCLC | Phase 2 | Status: RECRUITING